Life Science REIT plc (LON:LABS)

Life Science REIT Statistics

Total Valuation

LON:LABS has a market cap or net worth of GBP 131.25 million. The enterprise value is 251.99 million.

Market Cap	131.25M
Enterprise Value	251.99M

Important Dates

The last earnings date was Friday, September 19, 2025.

Earnings Date	Sep 19, 2025
Ex-Dividend Date	n/a

Share Statistics

LON:LABS has 350.00 million shares outstanding.

Current Share Class	350.00M
Shares Outstanding	350.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	3.88%
Owned by Institutions (%)	98.99%
Float	322.42M

Valuation Ratios

Price/FFO Ratio	n/a
Price/AFFO Ratio	n/a
PE Ratio	n/a
Forward PE	31.25
PS Ratio	6.24
PB Ratio	0.56
P/TBV Ratio	0.56
P/FCF Ratio	n/a
P/OCF Ratio	13.63
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-8.22
EV / Sales	11.98
EV / EBITDA	n/a
EV / EBIT	24.04
EV / FCF	-329.83

Financial Position

The company has a current ratio of 0.08, with a Debt / Equity ratio of 0.54.

Current Ratio	0.08
Quick Ratio	0.06
Debt / Equity	0.54
Debt / EBITDA	n/a
Debt / FCF	-165.45
Interest Coverage	0.95

Financial Efficiency

Return on equity (ROE) is -12.26% and return on invested capital (ROIC) is 1.76%.

Return on Equity (ROE)	-12.26%
Return on Assets (ROA)	1.69%
Return on Invested Capital (ROIC)	1.76%
Return on Capital Employed (ROCE)	4.42%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -11.14% in the last 52 weeks. The beta is -0.06, so LON:LABS's price volatility has been lower than the market average.

Beta (5Y)	-0.06
52-Week Price Change	-11.14%
50-Day Moving Average	38.28
200-Day Moving Average	40.00
Relative Strength Index (RSI)	45.31
Average Volume (20 Days)	660,846

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:LABS had revenue of GBP 21.04 million and -30.67 million in losses. Loss per share was -0.09.

Revenue	21.04M
Gross Profit	15.19M
Operating Income	10.48M
Pretax Income	-30.67M
Net Income	-30.67M
EBITDA	n/a
EBIT	10.48M
Loss Per Share	-0.09

Balance Sheet

The company has 5.66 million in cash and 126.40 million in debt, giving a net cash position of -120.74 million or -0.34 per share.

Cash & Cash Equivalents	5.66M
Total Debt	126.40M
Net Cash	-120.74M
Net Cash Per Share	-0.34
Equity (Book Value)	233.06M
Book Value Per Share	0.67
Working Capital	-127.52M

Cash Flow

In the last 12 months, operating cash flow was 9.63 million and capital expenditures -10.40 million, giving a free cash flow of -764,000.

Operating Cash Flow	9.63M
Capital Expenditures	-10.40M
Free Cash Flow	-764,000
FCF Per Share	-0.00

Margins

Gross margin is 72.20%, with operating and profit margins of 49.83% and -145.80%.

Gross Margin	72.20%
Operating Margin	49.83%
Pretax Margin	-145.80%
Profit Margin	-145.80%
EBITDA Margin	n/a
EBIT Margin	49.83%
FCF Margin	n/a

Dividends & Yields

LON:LABS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-23.37%
FCF Yield	-0.58%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4